These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9360843)

  • 1. The pattern of p53 and p21WAF1/CIP1 immunoreactivity in non-Hodgkin's lymphomas predicts p53 gene status.
    Mansukhani MM; Osborne BM; Zhong J; Matsushima AY
    Diagn Mol Pathol; 1997 Aug; 6(4):222-8. PubMed ID: 9360843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
    J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function.
    Chilosi M; Doglioni C; Magalini A; Inghirami G; Krampera M; Nadali G; Rahal D; Pedron S; Benedetti A; Scardoni M; Macrì E; Lestani M; Menestrina F; Pizzolo G; Scarpa A
    Blood; 1996 Nov; 88(10):4012-20. PubMed ID: 8916968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations.
    Oka T; Sarker AB; Teramoto N; Yoshino T; Akagi T
    Pathol Int; 1998 Jan; 48(1):15-21. PubMed ID: 9589459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene.
    Seta T; Imazeki F; Yokosuka O; Saisho H; Suzuki T; Koide Y; Isono K
    Dig Dis Sci; 1998 Feb; 43(2):279-89. PubMed ID: 9512119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic-pathological correlations.
    Girlando S; Slomp P; Caffo O; Amichetti M; Togni R; Dvornik G; Tomio L; Galligioni E; Dalla Palma P; Barbareschi M
    Virchows Arch; 1999 Dec; 435(6):559-65. PubMed ID: 10628797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas.
    Yook JI; Kim J
    Oral Oncol; 1998 May; 34(3):198-203. PubMed ID: 9692054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21.
    Maestro R; Gloghini A; Doglioni C; Piccinin S; Vukosavljevic T; Gasparotto D; Carbone A; Boiocchi M
    Blood; 1997 Apr; 89(7):2523-8. PubMed ID: 9116298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
    Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P
    J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma.
    Ito K; Sasano H; Matsunaga G; Sato S; Yajima A; Nasim S; Garret CT
    J Pathol; 1997 Nov; 183(3):318-24. PubMed ID: 9422988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between mutations in p53 gene and protein expression in human lymphomas.
    Martinez-Delgado B; Robledo M; Arranz E; Infantes F; Echezarreta G; Marcos B; Sanz C; Rivas C; Benitez J
    Am J Hematol; 1997 May; 55(1):1-8. PubMed ID: 9136910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).
    Louie DC; Offit K; Jaslow R; Parsa NZ; Murty VV; Schluger A; Chaganti RS
    Blood; 1995 Oct; 86(8):2892-9. PubMed ID: 7579380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.
    Kocialkowski S; Pezzella F; Morrison H; Jones M; Laha S; Harris AL; Mason DY; Gatter KC
    Br J Haematol; 1995 Jan; 89(1):55-60. PubMed ID: 7833277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
    Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation.
    Matsushita K; Kobayashi S; Kato M; Itoh Y; Okuyama K; Sakiyama S; Isono K
    Int J Cancer; 1996 Aug; 69(4):259-64. PubMed ID: 8797864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the gene mutation of p53 and the protein expression of p53 and Ki-67 in non-Hodgkin's lymphomas.
    Kuze T; Nakamura N; Hashimoto Y; Hojo H; Abe M; Wakasa H
    Pathol Int; 1996 Feb; 46(2):130-6. PubMed ID: 10846560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.